Germany · Delayed Price · Currency is EUR Verve Therapeutics Statistics
Total Valuation
ETR:EVK has a market cap or net worth of EUR 7.60 billion. The enterprise value is 11.81 billion.
| Market Cap | 7.60B |
| Enterprise Value | 11.81B |
Important Dates
The last earnings date was Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | May 29, 2025 |
Share Statistics
ETR:EVK has 466.00 million shares outstanding. The number of shares has decreased by -1.56% in one year.
| Current Share Class | 466.00M |
| Shares Outstanding | 466.00M |
| Shares Change (YoY) | -1.56% |
| Shares Change (QoQ) | -0.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 75.23% |
| Float | 251.64M |
Valuation Ratios
The trailing PE ratio is 17.81 and the forward PE ratio is 10.24.
| PE Ratio | 17.81 |
| Forward PE | 10.24 |
| PS Ratio | 0.52 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 2.29 |
| P/FCF Ratio | 14.81 |
| P/OCF Ratio | 5.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.36, with an EV/FCF ratio of 23.02.
| EV / Earnings | 27.86 |
| EV / Sales | 0.80 |
| EV / EBITDA | 6.36 |
| EV / EBIT | 14.21 |
| EV / FCF | 23.02 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.45 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | 8.83 |
| Interest Coverage | 3.76 |
Financial Efficiency
Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is 3.85%.
| Return on Equity (ROE) | 5.00% |
| Return on Assets (ROA) | 2.59% |
| Return on Invested Capital (ROIC) | 3.85% |
| Return on Capital Employed (ROCE) | 5.36% |
| Revenue Per Employee | 479,540 |
| Profits Per Employee | 13,825 |
| Employee Count | 30,669 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 4.16 |
Taxes
In the past 12 months, ETR:EVK has paid 178.00 million in taxes.
| Income Tax | 178.00M |
| Effective Tax Rate | 28.94% |
Stock Price Statistics
The stock price has decreased by -13.11% in the last 52 weeks. The beta is 0.94, so ETR:EVK's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -13.11% |
| 50-Day Moving Average | 18.24 |
| 200-Day Moving Average | 18.76 |
| Relative Strength Index (RSI) | 26.73 |
| Average Volume (20 Days) | 938,835 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ETR:EVK had revenue of EUR 14.71 billion and earned 424.00 million in profits. Earnings per share was 0.92.
| Revenue | 14.71B |
| Gross Profit | 3.78B |
| Operating Income | 813.00M |
| Pretax Income | 615.00M |
| Net Income | 424.00M |
| EBITDA | 1.67B |
| EBIT | 813.00M |
| Earnings Per Share (EPS) | 0.92 |
Balance Sheet
The company has 379.00 million in cash and 4.53 billion in debt, giving a net cash position of -4.15 billion or -8.91 per share.
| Cash & Cash Equivalents | 379.00M |
| Total Debt | 4.53B |
| Net Cash | -4.15B |
| Net Cash Per Share | -8.91 |
| Equity (Book Value) | 8.56B |
| Book Value Per Share | 18.40 |
| Working Capital | 1.73B |
Cash Flow
In the last 12 months, operating cash flow was 1.33 billion and capital expenditures -812.00 million, giving a free cash flow of 513.00 million.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -812.00M |
| Free Cash Flow | 513.00M |
| FCF Per Share | 1.10 |
Margins
Gross margin is 25.70%, with operating and profit margins of 5.53% and 2.88%.
| Gross Margin | 25.70% |
| Operating Margin | 5.53% |
| Pretax Margin | 4.18% |
| Profit Margin | 2.88% |
| EBITDA Margin | 11.32% |
| EBIT Margin | 5.53% |
| FCF Margin | 3.49% |
Dividends & Yields
This stock pays an annual dividend of 1.17, which amounts to a dividend yield of 7.18%.
| Dividend Per Share | 1.17 |
| Dividend Yield | 7.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 128.54% |
| Buyback Yield | 1.56% |
| Shareholder Yield | 8.74% |
| Earnings Yield | 5.58% |
| FCF Yield | 6.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETR:EVK has an Altman Z-Score of 2.08 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 7 |